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A novel ICK mutation
causes ciliary disruption and lethal
endocrine‑cerebro‑osteodysplasia syndrome
Machteld M. Oud1†, Carine Bonnard2†, Dorus A. Mans1†, Umut Altunoglu3, Sumanty Tohari4, Alvin Yu Jin Ng4,
Ascia Eskin5, Hane Lee6, C. Anthony Rupar7,8,9, Nathalie P. de Wagenaar1, Ka Man Wu1, Piya Lahiry10,
Gregory J. Pazour11, Stanley F. Nelson5,6, Robert A. Hegele7,12, Ronald Roepman1, Hülya Kayserili3,13,
Byrappa Venkatesh4, Victoria M. Siu7,8,9, Bruno Reversade2*†† and Heleen H. Arts1,7,9,12*††

Abstract
Background: Endocrine-cerebro-osteodysplasia (ECO) syndrome [MIM:612651] caused by a recessive mutation
(p.R272Q) in Intestinal cell kinase (ICK) shows significant clinical overlap with ciliary disorders. Similarities are strongest between ECO syndrome, the Majewski and Mohr-Majewski short-rib thoracic dysplasia (SRTD) with polydactyly
syndromes, and hydrolethalus syndrome. In this study, we present a novel homozygous ICK mutation in a fetus with
ECO syndrome and compare the effect of this mutation with the previously reported ICK variant on ciliogenesis and
cilium morphology.
Results: Through homozygosity mapping and whole-exome sequencing, we identified a second variant (c.358G > T;
p.G120C) in ICK in a Turkish fetus presenting with ECO syndrome. In vitro studies of wild-type and mutant mRFP-ICK
(p.G120C and p.R272Q) revealed that, in contrast to the wild-type protein that localizes along the ciliary axoneme
and/or is present in the ciliary base, mutant proteins rather enrich in the ciliary tip. In addition, immunocytochemistry
revealed a decreased number of cilia in ICK p.R272Q-affected cells.
Conclusions: Through identification of a novel ICK mutation, we confirm that disruption of ICK causes ECO syndrome, which clinically overlaps with the spectrum of ciliopathies. Expression of ICK-mutated proteins result in an
abnormal ciliary localization compared to wild-type protein. Primary fibroblasts derived from an individual with ECO
syndrome display ciliogenesis defects. In aggregate, our findings are consistent with recent reports that show that ICK
regulates ciliary biology in vitro and in mice, confirming that ECO syndrome is a severe ciliopathy.
Keywords: Endocrine-cerebro-osteodysplasia syndrome, ECO, Intestinal cell kinase, ICK, Short-rib thoracic dysplasia
syndrome, SRTD, Ciliopathy, Ciliary defects
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Background
We have previously described an extended consanguineous family from an Old Order Amish community affected
with neonatal lethal endocrine-cerebro-osteodysplasia
(ECO) syndrome, characterized primarily by endocrine,
cerebral, and skeletal abnormalities [1]. This is the only
family with ECO syndrome known to date. Through
homozygosity mapping and candidate gene sequencing, we identified a homozygous missense mutation
(c.815G > A [UCSC HG19: NM_014920] and p.R272Q
[UCSC: NP_055735]) in ICK, which encodes the intestinal cell kinase [1]. The ICK protein belongs to the roscross hybridizing kinase (RCK) family, which consists of
two other proteins, i.e., male germ cell-associated kinase
(MAK) and MAPK/MAK/MRK overlapping kinase
(MOK) [2–4]. Recent studies suggest that ICK is a ciliary
protein, involved in ciliogenesis and regulation of intraflagellar transport (IFT) [5–8]. Here, we describe a new
family with one affected fetus who was initially diagnosed
with short-rib thoracic dysplasia (SRTD), a clinically and
genetically heterogeneous group of disorders that are
characterized by skeletal abnormalities, including a narrow thorax, short ribs, short and bowed tubular bones,
and a number of extraskeletal features [MIM:PS208500].
Homozygosity mapping and whole-exome sequencing in
the affected fetus revealed a novel homozygous missense
mutation in ICK (c.358G > T; p.G120C), confirming that
disruptions in this gene cause ECO syndrome, a disorder
that shows marked clinical overlap with the short-rib thoracic dysplasia syndromes (SRTD), Majewski and MohrMajewski in particular [1]. Based on the clinical overlap
between ECO syndrome and these other ciliopathies, and
recent in vitro and mouse studies [5, 6] that showed that
ICK is a ciliary protein, we tested whether either mutation (p.G120C or p.R272Q) affects cilium presence, morphology, and function in ciliated mouse Inner Medullary
Collecting Duct 3 (mIMCD3) cells and in skin fibroblasts
derived from a p.R272Q patient with ECO syndrome.
Methods
Collection of human blood samples and ethics consent
and permissions

Blood samples were collected from twenty-two family members (I:1–I:4, II:1–II:15 and III:3–III:5) from
family 1. Genomic DNAs (gDNA) were extracted from
blood using a Qiagen kit (Cat# 74106) and from a fetal
skin sample (III:6) by standard procedure. Parents
gave their informed consent for study participation,
and the study was approved by the Clinical Research
Ethics Committees of Singapore (IRB #2013/1029/E)
and Istanbul Medical Faculty with protocol number
2012.743-IRB2.1061.
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Collection of human fibroblasts lines and ethics statement

A fibroblast cell line from an Old Order Amish patient
(family 2 in this paper) with ECO syndrome and two
healthy controls from non-Amish (control I) and Amish
(control II) communities were collected previously [1].
Tissues were obtained with informed consent, whereby
it should be noted that parents provided informed consent for the patient with ECO syndrome. Material was
collected with approval by the Office of Research Ethics
of the University of Western Ontario with the following
reference number: 07920E.
Genotyping and homozygosity mapping

14 individuals, including I:2, I:4, II:1, II:4, II:8, II:9, II:10,
II:11, II:12, II:13, III:3, III:4, III:5, and III:6, were genotyped using Illumina HumanCoreExome-12v1 BeadChips following manufacturer’s instructions. Call rates
were above 99 %, and gender and relationship were verified using Illumina GenomeStudio software. IdenticalBy-Descent (IBD) mapping was performed by searching
for homozygous regions in the unique affected individual
using custom programs written in Mathematica (Wolfram Research, Inc.). Allowing 1 % error rate, all homozygous regions that were >2 cM were examined. Candidate
regions were further refined by exclusion of common
homozygous segments with any of the 13 unaffected family members.
Whole‑exome sequencing

One microgram of high-molecular weight gDNA
extracted from fetus III:6 was used for exome capture
with ION TargetSeq Exome Kit. DNA was sheared using
Covaris M220 Focused-ultrasonicator (Covaris Inc.,
Woburn, MA, USA) to target an average fragment size of
200 bp. Shearing was followed by end repair, ligation of
adapters, nick repair, purification, size selection and final
amplification prior to exome capture as per TargetSeq
protocol. The amplified DNA was cleaned with Ampure
XP reagent (Agencourt, Boston, USA), and the DNA was
eluted in 30 µl low TE buffer. The libraries were quantified using a Qubit 2.0 Fluorometer (Life Technologies,
Carlsbad, CA, USA). The exome library was used for
emulsion PCR on an Ion OneTouch System or Ion Chef
System (Life Technologies, Carlsbad, CA, USA) following
the manufacturer’s protocol. Each library was sequenced
on an Ion Proton instrument (Life Technologies, Carlsbad, CA, USA) using one ION PI chip.
Sequence reads were aligned to the human reference
genome (Human GRCh37 (HG19) build) using Torrent
Mapping Alignment Program (TMAP) from the Torrent
Suite (v4.2.1). PCR duplicates in the BAM file were identified by the Filter Duplicates plugin (v4.2) and removed.
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The variants were called using the Torrent Variant Caller
(TVC) plugin (v4.2.1) and imported into Ion Reporter
(v4.2), where each variant was annotated using the “annotate single sample variants” workflow. Information including the associated gene; variant location; quality score;
coverage; amino acid change; predicted functional consequences using SIFT [9], PolyPhen2 [10], and Grantham
[11]; phyloP conservation scores [12]; and 5000 genomes
Minor Allele Frequencies were provided for each variant.
Common SNPs referenced in the NCBI database (ftp://
ftp.ncbi.nlm.nih.gov/pub/clinvar/vcf_GRCh37/) and the
Exome Sequencing Project (http://evs.gs.washington.edu/
EVS/) were filtered out. Variants that were predicted to
be synonymous or not having a location on either a coding exon, UTR, splice site junction, or flanking intron
were also removed. Variants were next compared to an
in-house database of 138 previously sequenced samples.
Those variants that were present in greater than 3 % of the
previously sequenced samples were removed.
Cloning

The ultimate ORF clone of human ICK cDNA
(IOH38087) in pENTR221 [1] was used to transfer ICK
into p733 (Life Technologies) through Gateway cloning (Life Technologies) according to the manufacturer’s
instructions. The p733 vector encodes a monomeric Red
Fluorescent Protein (mRFP). The p.G120C and p.R272Q
mutations were introduced through site-directed
mutagenesis, and constructs were validated with restriction digests and Sanger sequencing.
Cell culture

Localization studies of mutant and wild-type mRFP-ICK
were performed in two different cell lines, i.e., Human
Embryonic Kidney Cells 293 with Tantigen of SV40
(HEK293T) and mouse inner medullary collecting duct
3 (mIMCD3) cells. HEK293T cells were cultured in Dulbecco’s modified eagle’s medium (DMEM) with 10 %
fetal calf serum (FCS) and mIMCD3 cells in DMEM/F12
(1:1) supplemented with 10 % FCS. Fibroblasts from an
Old Order Amish patient with ECO syndrome and two
healthy controls from non-Amish (control I) and Amish
(control II) were cultured for immunocytochemistry
experimentation. Fibroblasts were cultured in DMEM
supplemented with 20 % FCS. All cell lines were cultured
at standard cell culture conditions.
Transfections in HEK293T and mIMCD3 cells

To analyze the cellular localization of mRFP-ICK in
HEK293T cells, these cells were cultured on sterile coverslips for 24 h. Cells were then transfected with p733 vector DNA encoding either wild-type or mutant (p.R272Q
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or p.G120C) mRFP-ICK using Lipofectamine (Life Technologies, Bleiswijk, The Netherlands) according to manufacturer’s instructions. 48 h post transfection, cells were
fixed in ice-cold methanol for 10 min. After a quick wash
with PBS, cells were permeabilized with 0.5 % Triton
X-100 in PBS. A drop of DAPI containing FluoromountG (Southern Biotech, Birmingham, AL, USA) was added
to the cells, and cover glasses were then placed on microscopic glass slides. The experiment was performed twice,
and >35 cells were counted per condition. Microscopic
analysis was conducted with a Zeiss Axio Imager Z2 fluorescence microscope (Zeiss, Sliedrecht, The Netherlands)
equipped with an ApoTome slider. Images were obtained
with ZEN 2012 software (Zeiss) and processed with Photoshop CS4 (Adobe Systems, San Jose, CA, USA) and FIJI
software. The protocol to determine the ciliary localization of mRFP-ICK in mIMCD3 cells was largely similar
compared to HEK293T studies; however, after culturing
mIMCD3 cells for 24 h on sterile coverslips followed by
24 h of transfection, culture medium was replaced by
serum-low medium containing 0.2 % FCS. mIMCD3 cells
were grown in this medium for 24 h to induce ciliogenesis. Subsequently, immunocytochemistry and microscopy were performed. The experiment was performed in
quadruplicate, and >50 cilia were analyzed per condition.
Immunocytochemistry

The mutational effects of p.R272Q were analyzed in
patient-derived fibroblasts from an affected individual
from family 2 compared to fibroblasts from healthy nonAmish (control I) and Amish (control II) controls. The
fibroblast cell lines were cultured on sterile coverslips
for 24 hours. Subsequently, ciliogenesis was induced
by replacing the culture medium for DMEM with 0.2 %
FCS for 48 h, followed by immunostaining. For this purpose, cells were washed in PBS, fixed in 2 % paraformaldehyde in PBS for 20 min permeabilized in 1 % triton
X-100 in PBS for 5 min. Prior to antibody binding, the
cells were blocked for 30 min in 2 % bovine serum albumin (BSA) in PBS. The following primary antibodies were
used: ARL13B (rabbit polyclonal, Proteintech Group,
Manchester, United Kingdom, 1:500) and RPGRIP1L
(custom-made guinea pig polyclonal; SNC039, 1:500).
Primary antibodies were diluted in 2 % BSA/PBS and
incubated for 1 h at room temperature. After washing with PBS, cells were incubated with fluorescentlylabeled secondary antibodies for 30 min. These include
anti-guinea pig IgG Alexa Fluor 568 and 647 (1:400), and
anti-rabbit IgG Alexa Fluor 488 (1:400). These antibodies were all obtained from Life Technologies (Bleiswijk,
The Netherlands). After washing cover glasses in PBS,
a drop of DAPI containing Fluoromount-G (Southern
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Biotech, Birmingham, AL, USA) was added to the cells.
Cover glasses were placed on microscopic glass slides,
and microscopic analysis was performed as previously
described.

Results
Clinical description of patient I

The affected fetus from family 1 (III:6, patient I) was
born to a consanguineous Turkish couple with three
unaffected children (III:3, III:4, and III:5), a newborn
who died 12 h after birth (III:1) due to an unknown etiology, and a still birth (SB) baby (III:2) (Fig. 1a). Antenatal ultrasound at 16 weeks of gestation showed cystic
hygroma, scalp edema ascites, bilateral ventriculomegaly, very short tubular bones and polydactyly of
hands and feet, and short ribs. A differential diagnosis
of SRTD was made. Follow-up scan at 19 weeks of gestation revealed large and hyperechogenic kidneys, and
a ventricular septal defect. Fetal karyotype was 46, XY.
The pregnancy was terminated at 33 weeks of gestation. In addition to hydropic appearance, short thorax,
and very short limbs, postmortem examination revealed
oro-facial-digital defects with syndromic craniofacial
features such as high and broad forehead, deep set eyes,
hypertelorism, very small nose, anteverted nares, midline pseudocleft of the upper lip, clefting of the soft palate, natal teeth, labiogingival fusion, irregular alveolar
crest, tongue fused to the lower palate, multiple frenula,
micrognathia, low-set and posteriorly rotated ears, postaxial heptadactyly of the hands, and preaxial heptadactyly of the feet. Sex reversal with hypoplastic labial folds
and anterior ectopic anus were also noted. Radiographs
showed resemblance to SRTD type II, with very short
tubular bones, torpedo-like femora, ovoid hypoplastic
tibiae, premature epiphyseal ossifications in the lower
limbs, short ribs, mildly defective ossification of the vertebrae, and small ilia with normal shape. Figure 1b shows
various phenotypic characteristics of patient I. The clinical features observed in patient 1 significantly overlap
with the features described of the affected infants in
family 2, described by Lahiry et al. [1]. Table 1 shows
a phenotypic comparison of the patients from both
families.
Genotyping and homozygosity mapping

Homozygosity mapping identified IBD regions in the
unique affected individual that were refined by exclusion of common homozygous segments with any of the
13 unaffected members of family 1. Four homozygous
loci (>2 CM), totaling 50 Mb, were delineated on chromosomes chr6: 33, 784, 864–55, 502, 257; chr8: 119, 886,
091–129, 606, 949; chr11: 120, 548, 318–131, 461, 292;
and chr20: 29, 834,107–37, 252, 342 (HG19) (Fig. 1c).
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Whole‑exome sequencing

Whole-exome sequencing of the fetus III:6 gDNA generated 15.6 Gb of data with an average read length of
169 bp. An average coverage of 194X was achieved over
the exome, with 96 % of bases covered at least 20X. A
total of 34,881 variants were identified across proteincoding exons, UTRs, splice sites, and flanking introns.
After applying all filters, a final set of 548 variants (49
homozygous and 499 heterozygous) were identified
(Additional file 1: Table S1). Only 5 homozygous variants
were found in the IBD blocks, of which 4 have been seen
in population or affect a non-conserved amino acid, leaving only one new protein-changing variant (c.358G > T)
in ICK (NM_014920.3) (Fig. 1c). Genotypes of the 376
flanking SNPs (Chr6: 50, 746, 213–54, 121, 367–HG19)
were found homozygous only in the fetus compared to
the 13 unaffected relatives (Additional file 2: Table S2).
We also confirmed by Sanger sequencing that this ICK
mutation was homozygous in the fetus, heterozygous
in both parents and either heterozygous, or wild type in
20 other relatives (Additional file 3: Figure S1). To date
(October 2015), this variant has not been reported in
any public databases such as the online Exome Aggregation Consortium (ExAC) (http://exac.broadinstitute.
org). Neither has the variant been reported in 1020 individuals who were whole exome sequenced by the Turkish
National Genomics Research groups under TUBITAK. In
addition, the p.G120C variant was not found in our inhouse database containing exomes of 72 other Turkish
individuals, which further underlines the rare character
of this mutation. This missense mutation (p.G120C) leads
to the alteration of a conserved glycine (Additional file 4:
Figure S2) and is distinct from the ICK mutation p.R272Q
previously reported in fetuses and newborns with ECO
syndrome [1] (Fig. 1d). Both mutations are located in the
serine-threonine protein kinase catalytic domain of ICK,
while p.R272Q also affects a nuclear localization signal
(Fig. 1d). To conclude, through identification of a second
ICK mutation in a fetus who displays ciliopathy related
features, we confirm that genetic changes in ICK gene
cause ECO syndrome.
Ciliary localization of ICK is altered in ICK mutants

We studied the cellular and ciliary localization of the two
homozygous missense mutations in ICK, c.815G > A,
p.R272Q known to cause ECO syndrome, and
c.358G > T, p.G120C from the family reported here. The
cellular localization of ICK was analyzed using HEK293T
cells that were transiently transfected with mRFP-ICK
constructs. As previously shown by Lahiry et al., wildtype ICK localized to the nucleus of these cells, whereas
the ICK p.R272Q mutant remained in the cytoplasm. On
the contrary, the novel ICK mutant p.G120C behaved as
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Fig. 1 Phenotypic characteristics of a proband with endocrine-cerebro-osteodysplasia (ECO) syndrome caused by a new missense mutation in
ICK. a Pedigree of Family 1. b Photographs and radiographs of the affected fetus. Note hydrops, tetramicromelia, narrow thorax, polydactyly with
hypoplastic fingers and toes, and craniofacial anomalies including high forehead, deep set eyes, cleft lip and palate, natal teeth, multiple frenula of
the upper lip, and low-set ears. c Homozygosity mapping delineated four candidate regions including one of 21 Mb on chromosome 6. Wholeexome sequencing of the fetus revealed a homozygous mismatch at position UCSC HG19 chr6: 52, 895, 863, causing one residue change p.G120C
in ICK protein (NP_055735). d The mutated residue p.G120C is localized in the catalytic domain of the serine-threonine kinase ICK. The previously
indentified variant p.R272Q that was found in ECO fetuses of an Old Order Amish family also resides in this domain. The glycine residue at p.120 is
conserved in all vertebrate ICK homologs. CL catalytic loop; AL activation loop; NLS nuclear localization signal
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Table 1 Clinical description and comparison of affected individuals carrying a homozygous mutation in ICK
Clinical features

Present fetus

Affected individuals combined/updated
from Lahiry et al. [1]

Pt I

IV-1, 2, 3, 4, 7, 8, new

Age at delivery (weeks)

33

Range 24–34

Karyotype

46, XY

46 (6/6), XY (4/6), XX (2/6)

Height (centile)

41 cm (10–25th)

3rd–10th (3/5), 90th–97th (2/5)

Weight (centile)

2450 g (90–97th)

90th–98th (5/7), 10th–25th (2/7)

Head circumference (centile)

34 cm (>97th)

90–>98th 4/6), 3rd–20th (2/6)

Autopsy

−

+ (3/6)

Oral
Cleft palate

Cleft soft palate

Midline (5/6), notch in alveolar (1/6)

Cleft lip

Midline notching

Midline (5/7), bilateral (2/7)

Presence of premaxilla
Prominent upper lip region

+

−

Hypoplastic/absent epiglottis

Unknown

Hypoplastic/absent larynx

Unknown

Craniofacial
Dolichocephaly
Midface hypoplasia
Microphthalmia
Retinal dysplasia
Deep set eyes
Fused eyelids
Hypotelorism
Flat and wide nasal bridge
Dysplastic and low-set ears
Micrognathia
Excess skin below chin
Single nostril
Natal teeth
Limbs-thorax
Micromelia
Polydactyly (postaxial)

−

+

+

Unknown
+

−

−

+

+

+

−

−

+

+, severe

Upper limbs, heptadactyly

Polydactyly (preaxial)

Lower limbs, heptadactyly

Brachydactyly

+, Severe

Syndactyly

4 limbs, total syndactyly

Hitch-hikers’ thumbs

−

Palmar creases abnormalities

Irregular, vertical creases

Ulnar deviation of hands

−

Bowing of forearms
Bowing of lower legs
Abducted hips
Sandal gap
Talipes equinovarus

+

−

+

−

+

+ (2/6)

+ (2/6)

+ (2/3)

+ (2/3)
+ (3/6)

+ (6/6)

+ (4/6), cystic (2/6)

+ (1/3)

+ (5/5)

+ (1/6)

+ (1/1)

+ (6/6)

+ (5/5)

+ (6/6)

+ (4/6)

+ (1/1)

+ (1/6)
+ (7/7)

+ (6/6)

−

+ (6/6)

+ (7/7)

+ (1/6)

+ (3/3)

+ (6/6)

+ (6/6)

+ (2/6)

+ (6/6)

+ (6/6)

–

Chest width

Narrow

Broad (1/6), narrow (1/6)

Prominent xyphoid

−

+ (1/6)

Very short with bowed radii and more severe
involvement of the lower limb

Short diaphysis (1/1)

Radiography
Abnormal long bones (radius, ulna, tibia, fibula)
Short and incurved ulnae
Short and ovoid tibiae

+

Very short, with very short fibula

+ (1/1)

+ (1/1)
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Table 1 continued
Clinical features

Present fetus

Affected individuals combined/updated
from Lahiry et al. [1]

Pt I

IV-1, 2, 3, 4, 7, 8, new

Abnormal humerus

Very short

Short diaphysis (1/1)

Abnormal femur

Very short, torpedo-like

Short and ovoid (1/1)

Spondylar involvement

+, Mildly defective ossification

Unknown

Premature epiphyseal ossification

+, Knees

Abnormal ilium

Small ilia with normal contour

Abnormal/hypoplastic acetabular roof

−

Central nervous system
Evidence of holoprosencephaly
Corpus callosum
Absence of septum pellucidum
Hydrocephalus (ventriculomegaly)

+ (3/3)

+ (2/2)

+

+ (2/2)

+

Unknown
Unknown

Cerebral cortex malformation

Unknown

Brainstem malformation

Unknown

Cerebellar abnormalities

+ (4/4)

−

Dysmorphic cerebral aqueduct

Hippocampus agenesis

+ (1/1)

+

Olfactory bulbs

+ (2/2)

+ (2/2)

+ (3/3)

+ (3/3)

+ (2/2)

−

Unknown

Leptomeningeal glioneuronal heterotopia

Unknown

Spinal cord malformation

Unknown

+ (2/2)

+ (1/1)

+ (1/2)

Endocrine system
Pituitary gland

Unknown

Adrenal glands

Unknown

+ Absent (2/2)

+ Absent (1/3), hypoplastic (2/3)

Other
Polyhydramnios
Fetal hydrops

+ (1/6)

−

+

Pulmonary hypoplasia

Unknown

Congenital heart defect

+, VSD

−

+ (1/1)

−

Gastrointestinal anomalies

Unknown

External genitalia abnormalities

Sex reversal with hypoplastic labial folds

Cryptorchidism

n/a

(Hyper)echogenic kidneys
Large kidneys
Squamous metaplasia of bladder

+ (2/3)

+ (4/7)

+ (1/6)c
+ (3/6)

+

+ (1/6)d

+

Unknown

+ (1/3)

Blank cells indicate that information was unavailable
a

Unknown
+ (1/1)

Information gathered from attending-physician reports

b

Report from International Skeletal Dysplasia Registry (Cedars-Sinai Medical Center) for patient 1

c

Feature is reported as patient had ambiguous external genitalia

d

Large kidneys displayed cystic tubules

wild-type ICK protein and localized in the HEK293T cell
nucleus (Fig. 2a, b). Since the mutation p.R272Q resides
in the nuclear localization signal domain of ICK, it may
affect the nuclear import of ICK protein. To examine the
effect of p.R272Q and p.G120C mutations on ciliogenesis, we transiently transfected mIMCD3 cells with mRFPICK constructs and stimulated the cells to form cilia by
serum starvation. While wild-type mRFP-ICK was often

present in the ciliary axoneme with or without enrichment at the ciliary base (92 %), both ICK mutants were
enriched at the ciliary tip in ~75 % of the cells (Fig. 2c,
d). Figure S3 in Additional file 5 visualizes each of the
ciliary phenotypes shown in Fig. 2d. Cilia of cells expressing mutant mRFP-ICK display an aberrant bulged tip in
~70 % of ciliated cells as visualized with ARL13B (Fig. 2c),
while ciliary length is not essentially altered (Additional
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(See figure on previous page.)
Fig. 2 Mutations found in ICK affect ciliogenesis and ciliary localization. a, b The cellular localization of ICK was analyzed in HEK293T cells overexpressing wild-type or two mutated forms of mRFP-ICK: p.R272Q (positive control, mutation previously studied in ECO infants) and p.G120C (new
mutation detected in the current study). Nuclei were stained with DAPI (blue) and mRFP-ICK proteins are shown in red. mRFP-ICK with the p.G120C
mutation showed the same nuclear localization as wild-type mRFP-ICK transfected cells, while nuclear import was completely lost when mRFP-ICK
with the p.R272Q mutation was expressed (Fisher’s exact test two-tailed p < 0.0001, >35 cells counted per condition). c, d The ciliary localization of
ICK was studied in mIMCD3 cells transiently transfected with wild-type or two mutant forms of mRFP-ICK: p.R272Q or p.G120C. Wild-type mRFPICK mostly localized to the ciliary axoneme and was often enriched at the ciliary base, while both mRFP-ICK mutants enriched at ciliary tips. Ciliary
axonemes were visualized with anti-ARL13B (green), ciliary transition zones that are present at the ciliary base were marked with anti-RPGRIP1L (pink),
mRFP-ICK constructs were shown in red, and nuclei were stained with DAPI (blue). Per construct >50 transfected, ciliated cells were counted. e, f
Cilium presence was studied in serum-starved fibroblasts derived from an ECO patient with a homozygous missense mutation in ICK (c.815G > A;
p.R272Q) and compared to fibroblasts derived from two healthy unrelated controls. Control I represents a non-Amish individual, while control II is
from the Amish community. Ciliogenesis was significantly reduced in fibroblasts from the ECO patient compared to the controls (Fisher’s exact test
two-tailed p < 0.0001 for both). At least 80 cells were counted per condition. Ciliary axonemes were visualized with anti-ARL13B (green), ciliary transition zones were marked with anti-RPGRIP1L (red), and nuclei were stained with DAPI (blue)

file 6: Figure S4). In summary, while the nuclear localization of ICK is only compromised by the p.R272Q mutation, we found that the ciliary localization is affected by
both p.R272Q and p.G120C mutants.
Ciliogenesis is reduced in ECO patient‑derived fibroblasts

To study the endogenous effect of the homozygous missense mutation p.R272Q on cilia, we monitored ciliogenesis and ciliary length in primary fibroblasts derived from
an ECO patient (Patient II) and compared them to cells
derived from two healthy controls, one non-Amish (Control I) and the other from the Amish community (Control
II). While 92 and 85 % of the control cells were ciliated,
only 24 % of patient-derived cells formed cilia (Fig. 2e, f ).
This was determined with a Fisher’s exact two-tailed test
that showed p < 0.0001 when comparing the patient sample to each of the controls. We did not observe any major
differences in ciliary length (Additional file 7: Figure S5).
In summary, we found that ECO patient-derived fibroblasts display reduced ciliogenesis, while the cilia that
form are of normal length.

Discussion
In this study, we identified a novel homozygous missense mutation (c.358G > T [UCSC HG19: NM_014920]
and p.G120C [UCSC: NP_055735]) in the ICK gene in a
consanguineous Turkish family with one affected fetus
who was initially clinically diagnosed as SRTD type II.
After mutation identification, the clinical features of the
proband were compared to those of the affected progeny
of a previously published Amish family with ECO syndrome who had a different homozygous missense mutation in ICK (p.R272Q) [1]. Although it remains unclear
if the Turkish proband had typical endocrine abnormalities seen in ECO syndrome, there was significant clinical
overlap with Amish fetuses, which leads us to conclude
that we identified the second family with ECO syndrome
world-wide. This study thus confirms that aberrations of

ICK can indeed cause severe phenotypes that resemble
the short-rib thoracic dysplasia spectrum. Our in vitro
studies performed in mIMCD3 cells show that mutant
mRFP-ICK with either p.R272Q or p.G120C accumulates
in the ciliary tip, while the wild-type protein localizes
along the ciliary axoneme with enrichment in the ciliary
base. Our findings are in line with the data published by
Moon et al. [6] who reported similar localization patterns
for both wild-type and mutant ICK (p.R272Q). In contrast, Chaya et al. [5] showed that wild-type ICK localizes to the ciliary tip and that this localization is lost in
the p.R272Q mutant. These different observations in
ICK localization may be due to variation in the expression level of ICK as well as the type and the position of
tags in the protein. Typical accumulations of protein at
ciliary tips were also observed in fibroblasts derived from
patients with ciliopathies such as asphyxiating thoracic
dystrophy [MIM:208500] [13] and cranioectodermal dysplasia [MIM:218330] [14]; cilia of these patients often
display abnormal ciliary tip accumulation of intraflagellar transport complex B (IFT-B) proteins. The protein
accumulations at ciliary tips may be due to defective IFT
and disruption in retrograde intraflagellar transport, i.e.,
transport occurring from the ciliary tip to its base [14].
Thus, the protein accumulations at the ciliary tip that we
observe may also be caused by defective IFT and suggest
a role for ICK in the regulation of this process. Recent
papers by Broekhuis et al. and Chaya et al. [5, 8] indeed
indicate that ICK coordinates IFT probably through
phosphorylation of KIF3A, a motor protein that drives
IFT from the ciliary base towards the tip. Considering
the presence of p.G120C and p.R272Q mutations in the
serine-threonine protein kinase domain, it is tempting to
speculate that both mutations affect phosphorylation of
KIF3A, thereby dysregulating IFT. While various reports
suggest that ICK is a regulator of cilia length [5, 6, 8], we
did not observe dramatic differences in the length of cilia
expressing mutant ICK nor in those cilia occurring on
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the apical surface of cells derived from an ECO patient
(Additional file 6: Figure S4 and Additional file 7: Figure S5). This may be in part be explained by the likely
hypomorph effects of the ECO syndrome-associated
missense mutations. We did, however, observe a significantly reduced number of cilia in ECO patient-derived
fibroblasts compared to two healthy controls. This may
explain the previously described hyperproliferative
behavior of these cells [15]. Our reasoning is that cilium
formation depends on docking of the mother centriole of
the centrosome to the plasma membrane from which the
cilium can then emerge. When cilia are unstable or do
not form, such as in ECO patient-derived cells, centrioles
become available for assembly of the mitotic spindle promoting cell division. The ciliogenesis defect seen in ECO
patient-derived fibroblasts is comparable to the defects
observed in Ick-deficient mouse embryonic fibroblasts
(MEFs), recently described by Chaya et al. [5].
Loss of Ick results in aberrant ciliary Hedgehog signaling in multiple murine organs and fibroblasts [5, 6], and
this pathway is also dysregulated in other ciliary chondrodysplasias that share clinical features with ECO syndrome and SRTD [16–19]. It is currently unclear how the
Hedgehog pathway is affected upon Ick depletion. One
hypothesis is that loss of Ick directly affects IFT thereby
altering Hedgehog signaling [5]. Another hypothesis is
that Ick depletion impacts mTORC1 signaling thereby
causing an imbalance in ciliary tubulin synthesis resulting in structural ciliary defects that in turn impact ciliary signaling [8]. In any case, many ECO and SRTD
syndrome-associated anomalies are probably due to disturbances of ciliary signaling cascades regulating human
development, including but probably not limited to the
Hedgehog pathway.

Conclusions
In conclusion, we here report a novel ICK mutation in a
family with ECO syndrome. This is the first replicative
allele, which confirms that ICK mutations are indeed
associated with severe SRTD resembling phenotypes. We
found ciliogenesis defects in fibroblasts derived from a
previously reported individual affected by ECO syndrome
and noted that expression of mutant ICK (p.R272Q and
p.G120C) results in aberrant localization of ICK in ciliary
tips. Although ciliary phenotypes vary slightly between
cells and species, our findings are in agreement with
recent reports on Ick knockout mice and murine Ick
depleted cells that reveal a role for Ick in ciliogenesis, ciliary transport, and regulation of cell signaling. Our study is
the first to show that ciliary defects occur in cells derived
from a patient with ECO syndrome with mutated ICK and
thereby provides additional support for inclusion of ECO
syndrome in the severe ciliary disease spectrum.
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